Cargando…
SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial
Background: Short stature is the most consistent characteristic feature of Turner syndrome (TS). Several studies have been performed to evaluate growth response to growth hormone (GH) for children with TS and shown that earlier and proper treatment with GH improves growth. Objectiv...
Autores principales: | Kim, Jinsup, Suh, Byung-Kyu, Ko, Cheol Woo, Lee, Kee-Hyoung, Yoo, Han-Wook, Shin, Choong Ho, Hwang, Jin Soon, Kim, Ho-Seong, Chung, Woo-Yeong, Kim, Chan Jong, Han, Heon-Seok, Jin, Dong Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553382/ http://dx.doi.org/10.1210/js.2019-SUN-259 |
Ejemplares similares
-
Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2021) -
Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial
por: Kim, Su Jin, et al.
Publicado: (2021) -
SUN-261 Growth Patterns over Two Years after Birth According to the Birth Weight and Length Percentile in Children Born Preterm
por: Kim, Seulki, et al.
Publicado: (2019) -
Efficacy of Short-Term Growth Hormone Treatment in Prepubertal Children with Idiopathic Short Stature
por: Kim, Ho-Seong, et al.
Publicado: (2014) -
The Population Prevalence, Thyroid Cancer and Mortality Risk for Turner Syndrome in South Korea Based on National Health Insurance Service (NHIS) Data
por: Kim, Sungeun, et al.
Publicado: (2021)